See the Complete Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
NHL
Social Media
World Cup
Formula 1
Music
Natural Disasters
Work
Donald Trump
Amazon
NBA
Artificial Intelligence
Immigration
Published • loading... • Updated

Q&A: Subcutaneous Daratumumab Eases Myeloma Time Burden

Summary by oncnursingnews.com
Subcutaneous daratumumab makes it easier for patients to find appointments that fit with their lifestyles and schedules, according to Gina Fries, PA-C.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
oncnursingnews.comoncnursingnews.com

Q&A: Subcutaneous Daratumumab Eases Myeloma Time Burden

Subcutaneous daratumumab makes it easier for patients to find appointments that fit with their lifestyles and schedules, according to Gina Fries, PA-C.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

oncnursingnews.com broke the news in on Wednesday, June 25, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Lifestyle icon

Lifestyle

Pennsylvania icon

Pennsylvania

News
For You
SearchBlindspotLocal